Mobile

A study to evaluate the safety and efficacy of PF-06650833 in subjects with moderate to severely active rheumatoid arthritis who have an incomplete response to methotrexate treatment Estudio par...

Update Il y a 4 ans
Reference: EUCTR2016-002337-30

A study to evaluate the safety and efficacy of PF-06650833 in subjects with moderate to severely active rheumatoid arthritis who have an incomplete response to methotrexate treatment Estudio para evaluar la eficacia y seguridad de PF-06650833 en sujetos con artritis reumatoide de moderada a severa que han presentado una respuesta inadecuada a metotrexato (MTX)

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To evaluate the efficacy of PF-06650833 at 12 weeks, in subjects with moderate - severe active RA who have had an inadequate response to methotrexate. Evaluar la eficacia de PF-06650833 a las 12 semanas, en sujetos con AR active moderada-severa con inadecuada respuesta a metotrexato.

Inclusion criteria

  • Rheumatoid Arthritis,Aritritis reumatoide

Links